Beyond weight loss, the expanding therapeutic landscape of GLP-1 agonists now includes cardiovascular risk reduction, peripheral artery disease management, and active clinical trials for neurodegenerative disorders and substance use disorderswith over 15 global trials underway for the latter indication alone
Also, dem explain say dis product fit expose people to hepatitis B and C den even transmission of HIV sake wrong use of needles.
In other medical conditions, GLP-1 receptor agonists have been shown to reduce inflammatory cytokines, lower oxidative stress, and improve visceral inflammation
She is also diabetes clinical colead for the Health Equity Accelerator at Boston Medical Center (BMC), BUs primary teaching hospital
You're gonna have some oxidize in products, but I would argue like, okay, the bigger problem is that you're eating a lot of fried food, right